Compounded Wegovy and Zepbound may disappear under new FDA rules
The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...
Health on MSN7d
Zepbound Is Now Available in Additional Doses at Lower Costs
Fact checked by Nick Blackmer Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, ...
Clinical Pain Advisor1d
Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance
Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Health News Florida9d
Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Indianapolis Business Journal8d
Zepbound raises profile of Lilly’s direct-to-consumer sales initiative
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
Verywell Health on MSN13d
Eli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance Coverage
Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Fierce Healthcare6d
Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
BioPharma Dive3d
Novo’s Wegovy successor disappoints in second large trial
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
Makers of Wegovy and Zepbound cut prices for those without insurance
The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...